HeartWare International, Inc.

500 Old Connecticut Path,
Framingham, Massachusetts 01701
United States,
(508) 739-0950
www.heartware.com

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure. Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options. HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.4/yr) # 1 1 - 1 - - 3
vol $8M $30M $38M
Sell (0.2/yr) # - - - - 1 - 1
vol $340M $340M
  4

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest CircuLite, Inc.
$30M (2013-12-01)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Valtech Cardio Ltd.
$340M (2016-11-28)

HeartWare International was acquired by Medtronic on June 27, 2016.

HeartWare International has acquired 3 companies of its own, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

HeartWare International’s largest acquisition to date was in 2013, when it acquired CircuLite for $30M. It’s largest disclosed sale occurred in 2016, when it sold Valtech Cardio to Edwards Lifesciences for $340M. HeartWare International has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include medical products (100%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 329 medical products companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Medtronic, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 7 platform acquisitions.

Join Mergr and gain access to HeartWare International’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.